Table
of Contents
|
|
|
|
Preface |
xiii |
1 |
Disease Screening |
|
|
Abdominal
Aortic Aneurysm |
2 |
|
Alcohol
Abuse & Dependence |
3 |
|
Anemia |
4 |
|
Atlention-Deficit/Hyperactivity Disorder |
6 |
|
Bacteriuria, Asymptomatic |
7 |
|
Bacterial Vaginosis |
8 |
|
Barrett’s
Esophagus |
9 |
|
Cancer |
|
|
Bladder |
10 |
|
Breast |
12 |
|
Cervical |
19 |
|
Colorectal |
23 |
|
Endometrial |
28 |
|
Gastric |
30 |
|
Liver |
31 |
|
Lung |
32 |
|
Oral |
34 |
|
Ovarian |
35 |
|
Pancreatic |
37 |
|
Prostate |
38 |
|
Skin |
41 |
|
Testicular |
42 |
|
Thyroid |
43 |
|
Carotid
Artery Stenosis |
44 |
|
Celiac
Disease |
45 |
|
Chlamydia |
46 |
|
Cholesterol
& Lipid Disorders |
47 |
|
Children |
47 |
|
Adults |
48 |
|
Coronary
Artery Disease |
50 |
|
Dementia |
53 |
|
Depression |
54 |
|
Developmental
Dysplasia of the Hip |
55 |
|
Diabetes
Mellitus |
|
|
Gestational |
56 |
|
Type 2 |
57 |
|
Falls in the
Elderly |
59 |
|
Family
Violence and Abuse |
60 |
|
Gonorrhea |
61 |
|
Group B
Streptococcal Disease |
62 |
|
Growth
Abnormalities, Infant |
63 |
|
Hearing
Impairment |
64 |
|
Hemochromatosis |
65 |
|
Hemoglobinopathies |
67 |
|
Hepatitis B
Virus Infection, Chronic |
68 |
|
Hepatitis C
Virus Infection, Chronic |
69 |
|
Herpes
Simplex Virus, Genital |
71 |
|
Human
Immunodeficiency Virus |
72 |
|
Hypertension |
|
|
Children
& Adolescents |
74 |
|
Adults |
75 |
|
Illicit Drug
Use |
77 |
|
Kidney
Disease, Chronic |
78 |
|
Lead
Poisoning |
79 |
|
Motor
Vehicle Safety |
81 |
|
Newborn
screening |
82 |
|
Obesity |
83 |
|
Children |
|
|
Adults |
|
|
Osteoporosis |
85 |
|
Phenylketonuria |
86 |
|
RH (D)
Incompatibility |
87 |
|
Scoliosis |
88 |
|
Speech &
Language Delay |
89 |
|
Syphilis |
90 |
|
Thyroid
Disease |
91 |
|
Pregnancy
and Postpartum |
92 |
|
Tobacco Use |
93 |
|
Tuerculosis, Latent |
95 |
|
Visual Impairment, Glaucoma, or Cataract |
96 |
2 |
Disease Prevention |
|
|
Primary Prevention of
Cancer: NCI Evidence Summary |
98 |
|
Catheter-Related Bloodstream
Infections |
106 |
|
Dental Caries |
107 |
|
Diabetes Mellitus, Type 2 |
108 |
|
Domestic Violence |
109 |
|
Endocarditis |
111 |
|
Falls in the Elderly |
112 |
|
Gonorrhea, Ophthalmia Neonatorum |
113 |
|
Group B
Streptococcal Infection |
114 |
|
Human
Immunodeficiency Virus, Opportunistic Infections |
115 |
|
Prevention
Among HIV-Infected Adults |
116 |
|
Prevention
Among HIV-Exposed and HIV-Infected Infants and children |
120 |
|
Hypertension |
124 |
|
Lifestyle
Modifications |
125 |
|
Immunizations |
|
|
Adults |
126 |
|
Infants and
Children |
127 |
|
Children and
Adolescents |
128 |
|
Influenza |
|
|
Chemoprophylaxis |
129 |
|
Vaccination |
130 |
|
Motor
Vehicle Injury |
131 |
|
Myocardial
Infarction |
132 |
|
Neural Tube
Defects |
139 |
|
Obesity |
140 |
|
Osteoporotic Hip Fractures |
141 |
|
Pressure
Ulcers |
142 |
|
Sexually
Transmitted Infections |
144 |
|
Stroke |
145 |
|
Sudden
Infant Death Syndrome |
150 |
|
Tobacco Use |
151 |
|
Venous Thromboembolism |
152 |
|
Prophylaxis
in Nonsurgical Patients |
152 |
|
Surgical
Patients |
157 |
3 |
Disease Management |
|
|
Adrenal
Incidentalomas |
162 |
|
Alcohol Use
Disorders |
163 |
|
Anaphylaxis |
164 |
|
Androgen
Deficiency Syndrome |
165 |
|
Anxiety |
166 |
|
Asthma |
167 |
|
Atrial Fibrillation |
|
|
Management |
169 |
|
HAS-BLED
Bleeding Risk Score for Warfarin Therapy |
176 |
|
Thromboembolic Risk Scores in Nonvalvular
Atrial Fibrillation |
178 |
|
Risk Factors
for Stroke and Thromboembolism in Nonvalvular AF |
178 |
|
Attention-Deficit
Hyperactivity Disorder |
179 |
|
Autism |
180 |
|
Barrett’s
Esophagus |
181 |
|
Benign Prostatic Hyperplasia |
182 |
|
Bronchitis,
Acute |
184 |
|
CA
Survivorship |
185 |
|
Late Effects
of CA Treatments |
|
|
Carotid
Artery Stenosis |
190 |
|
Cataract in
Adults |
|
|
Evaluation
& Management |
191 |
|
Cerumen Impaction |
193 |
|
Cholesterol
& Lipid Management |
|
|
Adults |
194 |
|
Children |
197 |
|
Colitis, Clostridium
Difficile |
198 |
|
Constipation |
199 |
|
Contraception,
Emergency |
200 |
|
Contraceptive Use |
|
|
Changes Classifications |
201 |
|
Recommendations |
208 |
|
Additional
Changes |
212 |
|
Chronic
Obstructive Pulmonary Disease |
|
|
COPD
Exacerbations |
213 |
|
Stable COPD |
214 |
|
Coronary
Artery Disease |
|
|
Therapy Use
of Triple Anticoagulation Treatment |
216 |
|
Therapy for
Unstable Angina |
218 |
|
Delirium |
219 |
|
Dementia |
220 |
|
Alzheimer’s
Disease |
221 |
|
Depression |
222 |
|
Diabetes
Mellitus |
|
|
Type 1 |
223 |
|
Type 2 |
225 |
|
Foot
Problems, Inpatient Management |
231 |
|
Erectile
Dysfunction |
232 |
|
Glaucoma,
Chronic Open Angle |
233 |
|
Headache |
|
|
Migraine
Prophylaxis |
234 |
|
Hearing
Loss, Sudden |
243 |
|
Heart
Failure |
244 |
|
Heart
Failure 2012 |
245 |
|
Hemochromatosis |
247 |
|
Hepatitis B
Virus |
248 |
|
Hepatitis C
Virus |
249 |
|
Hoarseness |
250 |
|
Human
Immunodeficiency Virus Adults and Children |
251 |
|
Antiretroviral
Therapy |
253 |
|
Antiretroviral
Use |
254 |
|
Pregnancy |
255 |
|
Hypertension |
|
|
Initiating
Treatment |
257 |
|
Lifestyle
Modifications |
258 |
|
Recommended
Medications for Compelling Indications |
259 |
|
Refractory
Hypertension |
259 |
|
Children and
Adolescents |
260 |
|
2012 Joint
National Committee HTN |
262 |
|
Hypogonadism, Male |
263 |
|
Infertility,
Male |
264 |
|
Influenza |
265 |
|
Kidney
Disease |
|
|
Chronic |
266 |
|
Chronic-Mineral
and Bone Disorders |
268 |
|
Kidney
Stones |
269 |
|
Back Pain,
Low |
270 |
|
Evaluation
and Management |
271 |
|
Menopause |
272 |
|
Metabolic
Syndrome |
|
|
Identification
& Management |
273 |
|
Methicillin-Resistant Staphylococcus Aureus |
274 |
|
Febrile Neutropenia |
276 |
|
Obesity
Management |
278 |
|
Osteoarthritis |
280 |
|
Osteoporosis |
|
|
Evaluation
and Management |
281 |
|
Glucocorticoid-Induced |
284 |
|
Otitis Media, Acute |
286 |
|
Palliative
& End-of-Life Care |
|
|
Pain
Management |
288 |
|
Abnormal Pap
Smear |
289 |
|
Perioperative Cardiovascular Evaluation |
290 |
|
Approach to Pharyngitis, Acute |
292 |
|
Pneumonia,
Community-Acquired Evaluation |
293 |
|
Suspected
Pathogens |
294 |
|
Pregnancy |
|
|
Routine
Prenatal Care |
295 |
|
Perinatal & Postnatal Guidelines |
298 |
|
Preterm Labor,
Tocolysis |
299 |
|
Psoriasis |
|
|
Plaque-Type |
300 |
|
Psoriatic
Arthritis |
301 |
|
Respiratory
Tract Infections, Lower |
303 |
|
Rheumatoid
Arthritis |
|
|
Biologic
Disease-Modifying Antirheumatic Drugs |
304 |
|
Nonbiologic Disease-Modifying Antirheumatic
Drugs |
305 |
|
Noninfectious
Rhinitis Management |
306 |
|
Seizures,
Febrile |
307 |
|
Sexually
Transmitted Diseases |
308 |
|
Syphilis |
315 |
|
Management
of Thyroid Nodules |
316 |
|
Thyroid
Disease |
|
|
Hyperthyroidism |
317 |
|
Pregnancy
and Postpartum |
319 |
|
Tobacco
Cessation |
320 |
|
Tonsillcctomy |
323 |
|
Tremor,
Essential |
324 |
|
Tuberculosis,
Multidrug-Resistant |
325 |
|
Urinary
Incontinence |
|
|
Stress |
326 |
|
Men |
327 |
|
Women |
328 |
|
Urinary
Tract Infections (UTIs) |
329 |
|
Lower
Urinary Tract Symptoms (LUTS) |
332 |
|
Venous Thromboembolism |
|
|
Diagnosis
and Treatment of Venous |
|
|
Thromboembolism (VTE) Wells Criteria |
333 |
|
Deep Vein
Thrombosis (DVT) |
334 |
|
Diagnosis of
Deep Venous Thrombosis (DVT) |
337 |
|
Pulmonary
Embolus (PE) |
338 |
|
Diagnosis of
Pulmonary Embolism (PE) |
339 |
|
New Oral
Anticoagulants and Warfarin |
340 |
|
Vertigo,
Benign Paroxysmal Positional (BPPV) |
341 |
4 |
APPENDICES |
|
Appendix I |
Screening Instruments |
|
|
Alcohol
Abuse |
344 |
|
Depression |
347 |
|
Geriatric
Depression Scale |
351 |
Appendix II |
Functional Assessment Screening in the
Elderly |
352 |
Appendix III |
Screening and Prevention Guidelines in
Perspective |
354 |
Appendix IV |
95th Percenlilc
of Blood Pressure |
|
|
Boys |
356 |
|
Girls |
357 |
Appendix V |
Body Mass Index Conversion Table |
358 |
Appendix VI |
Cardiac Risk—Farmingham
Study |
|
|
Men |
359 |
|
Women |
361 |
Appendix VII |
Estimate of 10-Year Stroke Risk |
|
|
Men |
363 |
|
Women |
364 |
Appendix VIII |
Immunizations Schedules |
366 |
Appendix IX |
Professional Soeicties
and Governmental Agencies |
376 |
|
Index |
379 |
|
|
|